Dr Vinay Prasad, the FDA's Chief Medical and Scientific Officer, resigned from his post on 29 July 2025 after mounting criticism over vaccine restrictions and a controversial gene therapy decision. The resignation, which was confirmed by the Department of Health and Human Services (HHS), came just months after Prasad's rapid rise within the federal agency.
According to officials, he will return to California to spend time with family, citing a desire 'not to be a distraction' to the FDA's work. His exit followed clashes over key regulatory decisions and growing pressure from political figures.
